[Form 4] Amcor plc Insider Trading Activity

Rhea-AI Filing Summary

Amcor plc (AMCR) Form 4 filed by Susana Suarez Gonzalez reports insider transactions on 09/15/2025. The filing shows a sale of 74,174 ordinary shares and grants/awards acquired the same date: 23,367 restricted stock units (RSUs) vesting 09/15/2027, 43,363 RSUs that vest ratably over three years, and 710,976 employee stock options with an exercise price of $8.28, exercisable beginning 09/15/2028 and expiring 09/15/2035. Each RSU converts to one ordinary share on vesting. The transactions were reported by an attorney-in-fact on 09/17/2025.

Positive

• Grant of 710,976 employee stock options at a fixed exercise price of $8.28, providing long-term incentive alignment
• RSU awards totaling 66,730 ordinary shares (23,367 vesting on 09/15/2027 and 43,363 vesting ratably over three years) that convert one-for-one on vesting

Negative

• Disposition of 74,174 ordinary shares reported on 09/15/2025
• Large option grant could increase potential dilution if fully exercised (710,976 shares underlying options)

Insights

Financial Analyst

TL;DR: Insider sold a modest block of shares while receiving substantial equity awards, mainly long-dated options.

The sale of 74,174 ordinary shares is an explicit disposition recorded on 09/15/2025. Concurrently the reporting person received equity-based compensation consisting of 23,367 time‑vesting RSUs, 43,363 RSUs vesting ratably over three years, and 710,976 employee stock options at a $8.28 exercise price exercisable from 09/15/2028 to 09/15/2035. These awards are typical of executive compensation design that combines time-based share units and long-dated options to align long-term incentives. The sizable option grant materially increases potential future dilution if exercised but carries exercise price and multi-year vesting/exercise windows that condition value on sustained performance and share price appreciation.

Corporate Governance Expert

TL;DR: Transactions appear consistent with routine executive compensation and a reported share disposition; no regulatory or governance red flags shown.

The Form 4 discloses a sale and multiple equity grants reported under Section 16. RSUs convert one-for-one to ordinary shares and vest on stated schedules; options have a clear exercise price and long exercise window. The filing was signed by an attorney-in-fact, indicating procedural reporting compliance. The document contains no statements of derivation, related-party transactions, or deviations from standard award terms; therefore, based solely on this filing, there is no indication of governance irregularities. Materiality for shareholders depends on aggregate company‑level dilution and executive roles not specified in the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Suarez Gonzalez Susana

(Last) (First) (Middle)

83 TOWER ROAD NORTH

(Street)

WARMLEY, BRISTOL X0 BS308XP

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amcor plc [ AMCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EX. VP & CHIEF HUMAN RESOURCES

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares								74,174	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/15/2025		A		23,367		09/15/2027	09/15/2027	Ordinary Shares	23,367	$0	23,367	D
Employee Stock Options	$8.28	09/15/2025		A		710,976		09/15/2028	09/15/2035	Ordinary Shares	710,976	$0	710,976	D
Restricted Stock Units	(1)	09/15/2025		A		43,363		(2)	(2)	Ordinary Shares	43,363	$0	43,363	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one ordinary share of Amcor upon vesting of the restricted stock units.

2. The restricted stock units vest ratably on each of the first three anniversaries of the grant date.

	/s/ Damien Clayton, Attorney-in-Fact	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Susana Suarez Gonzalez report on Form 4 for AMCR?

The Form 4 reports a sale of 74,174 ordinary shares and acquisitions on 09/15/2025 of 23,367 RSUs (vesting 09/15/2027), 43,363 RSUs vesting ratably over three years, and 710,976 employee stock options at $8.28.

When do the RSUs and options reported in the AMCR Form 4 vest or become exercisable?

One RSU tranche vests on 09/15/2027; the other RSUs vest ratably across the first three anniversaries of the grant date. The employee stock options are exercisable beginning 09/15/2028 and expire 09/15/2035.

What is the exercise price of the options granted to the reporting person in AMCR Form 4?

The exercise price for the employee stock options is $8.28 per share.

Who signed and filed the AMCR Form 4 and when was it filed?

The Form 4 was signed by /s/ Damien Clayton, Attorney-in-Fact and dated 09/17/2025.

Do the RSUs convert to ordinary shares and at what ratio?

Yes. Each restricted stock unit represents a contingent right to receive one ordinary share upon vesting.